tiprankstipranks
Charles River Laboratories Reports 2024 Q3 Financial Results
PremiumCompany AnnouncementsCharles River Laboratories Reports 2024 Q3 Financial Results
1M ago
Charles River upgraded to Hold from Underperform at CLSA
Premium
The Fly
Charles River upgraded to Hold from Underperform at CLSA
1M ago
Charles River price target raised to $211 from $190 at Baird
Premium
The Fly
Charles River price target raised to $211 from $190 at Baird
1M ago
McDonald’s, Ford, Pfizer report Q3 earnings beats: Morning Buzz
PremiumThe FlyMcDonald’s, Ford, Pfizer report Q3 earnings beats: Morning Buzz
2M ago
Charles River shipments of research monkeys spark investigation, STAT says
Premium
The Fly
Charles River shipments of research monkeys spark investigation, STAT says
2M ago
Charles River initiated with an Underperform at CLSA
Premium
The Fly
Charles River initiated with an Underperform at CLSA
2M ago
Charles River, Lundbeck in deal to use Logica for neurological disease drugs
PremiumThe FlyCharles River, Lundbeck in deal to use Logica for neurological disease drugs
3M ago
Charles River downgraded to Neutral at BofA on biopharma concerns
Premium
The Fly
Charles River downgraded to Neutral at BofA on biopharma concerns
3M ago
Charles River downgraded to Neutral from Buy at BofA
Premium
The Fly
Charles River downgraded to Neutral from Buy at BofA
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100